Status:
COMPLETED
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
Lead Sponsor:
University Hospital, Motol
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
This study investigates potential protective effect of atorvastatin pre-treatment in patient with stable coronary artery disease undergoing percutaneous coronary intervention (PCI). Patient are random...
Detailed Description
Randomized studies have shown that pre-treatment with atorvastatin may reduced periprocedural myocardial in patient with stable angina during elective PCI. These data provide evidence-based support fo...
Eligibility Criteria
Inclusion
- stable angina in last month
- indication for percutaneous coronary intervention
- informed consent
Exclusion
- acute coronary syndrome in last 14 days
- renal insufficiency (creatinine more 150 µmol/l)
- diseases severely limiting prognosis
- immunosuppressive treatment
- statin one month before randomization
- occlusion of the coronary artery
- previous participation in this study
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00469326
Start Date
April 1 2005
End Date
December 1 2008
Last Update
January 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, CardioVascular Center, University Hospital Motol
Prague, Czechia, 150 18